Your session is about to expire
← Back to Search
Inhaled Chemotherapy + IV Chemotherapy for Non-Small Cell Lung Cancer
Study Summary
This trial will test whether adding inhaled chemotherapy to a standard IV chemotherapy treatment plan increases efficacy while also measuring any additional toxicities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- My kidney function is normal, based on creatinine levels or clearance.My cancer has spread beyond my lungs and is not responding to standard treatments.My lung cancer is advanced but hasn't spread to my brain, and it can't be removed by surgery.My doctor thinks my lung blockage might stop inhaled medicine from working well.I have not had chemotherapy or biologic therapy for lung cancer.My lung function tests show I have good breathing capacity and oxygen levels.I am not pregnant or breastfeeding and will use birth control during and for 3 months after the study.I am fully active or can carry out light work.I have an ongoing serious infection that isn't getting better with treatment.My lung condition can be measured or evaluated.I haven't had chemotherapy for any cancer other than NSCLC in the last 5 years and no lung damage from it.My bone marrow, liver, and kidneys are functioning well.I haven't had radiation to my lungs, but chest wall or breast radiation is okay if there's no lung damage.I am older than 18 years.I have fully recovered from any previous surgeries.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open spots for individuals to join this trial?
"According to clinicialtrials.gov, this medical study is no longer enrolling patients as the trial was last updated in April 2006. Nonetheless, there are still 670 other trials actively recruiting across the country."
Does this trial accept participants aged 80 or younger?
"The enrollment criteria for this medical trial requires that participants are 18 or older but not yet 65 years old."
Is it feasible for me to join this research project?
"This trial is seeking 30 individuals with non-small cell lung carcinoma (nsclc) over the age of 18. Eligibility criteria include: Never having received a chemotherapeutic or biologic therapy for lung cancer, being an adult aged >18 years, and exhibiting an Eastern Cooperative Oncology Group Performance Status score of 0 to 1."
What is the geographical scope of this trial's operations?
"This medical trial is running in numerous locations, most prominently the Yale University Cancer Center located in New Haven Connecticut, Southern Nevada Cancer Research Foundation situated in Las Vegas, and Arthur G James Cancer Hospital & Richard Solove Research Institute at Ohio State University found in Columbus."
Share this study with friends
Copy Link
Messenger